The McGill University Health Centre is partnering with Canadian health technology company Gray to streamline chemotherapy scheduling at the Cedars Cancer Centre, a project funded by Scale AI.
“Thanks to this innovative project, we hope to be able to treat more patients, faster, using the same resources,” said Dr. Lucie Opatrny, president and executive director of the MUHC. “This is a great example of how artificial intelligence can help us improve efficiency while maintaining the highest standards of care.
“It also means that nurses who previously spent time scheduling will be able to dedicate more time to being at the bedside, where they are most needed.”
Related:
Gray’s AI platform, GrayOS, will analyze treatment durations, pharmacy preparation times and chair and nurse availability to help balance workloads and improve day-to-day operations.
“This partnership is about reimagining how we deliver care,” says Dr. Alan Forster, the MUHC’s director of innovation, transformation and clinical performance. “Scheduling chemotherapy treatments is a very complex and time-consuming activity. By using AI to coordinate it, we can improve the patient experience while supporting our teams in providing timely, efficient care.”
The project, running from early 2026 to December 2026, will be developed with input from nurses, pharmacists and schedulers to integrate the system into clinical workflows.
“This project reflects our shared commitment to continuously innovate in order to improve the care experience for both patients and staff,” added Alain Biron, director of nursing at the MUHC. “When we can better align schedules, balance workloads and anticipate needs, everyone benefits, most importantly, our patients.”
